These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 11240975)
1. The effect of rifampin administration on the disposition of fexofenadine. Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975 [TBL] [Abstract][Full Text] [Related]
2. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446 [TBL] [Abstract][Full Text] [Related]
3. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371 [TBL] [Abstract][Full Text] [Related]
4. Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics. Yamada S; Yasui-Furukori N; Akamine Y; Kaneko S; Uno T Ther Drug Monit; 2009 Dec; 31(6):764-8. PubMed ID: 19855315 [TBL] [Abstract][Full Text] [Related]
5. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Yasui-Furukori N; Uno T; Sugawara K; Tateishi T Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527 [TBL] [Abstract][Full Text] [Related]
6. Effect of St John's wort on the pharmacokinetics of fexofenadine. Wang Z; Hamman MA; Huang SM; Lesko LJ; Hall SD Clin Pharmacol Ther; 2002 Jun; 71(6):414-20. PubMed ID: 12087344 [TBL] [Abstract][Full Text] [Related]
7. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment. Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent interaction between lopinavir/ritonavir and fexofenadine. van Heeswijk RP; Bourbeau M; Campbell P; Seguin I; Chauhan BM; Foster BC; Cameron DW J Clin Pharmacol; 2006 Jul; 46(7):758-67. PubMed ID: 16809801 [TBL] [Abstract][Full Text] [Related]
9. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism. Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853 [TBL] [Abstract][Full Text] [Related]
10. Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin. Smith DA; Chandler MH; Shedlofsky SI; Wedlund PJ; Blouin RA Br J Clin Pharmacol; 1991 Dec; 32(6):735-9. PubMed ID: 1768567 [TBL] [Abstract][Full Text] [Related]
11. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410 [TBL] [Abstract][Full Text] [Related]
12. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Russell T; Stoltz M; Weir S Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426 [TBL] [Abstract][Full Text] [Related]
14. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine. Uno T; Shimizu M; Sugawara K; Tateishi T Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786 [TBL] [Abstract][Full Text] [Related]
15. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. Jin MJ; Han HK J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299 [TBL] [Abstract][Full Text] [Related]
16. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone. Dilger K; Hofmann U; Klotz U Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630 [TBL] [Abstract][Full Text] [Related]
17. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination. Kharasch ED; Walker A; Hoffer C; Sheffels P J Clin Pharmacol; 2005 Jan; 45(1):79-88. PubMed ID: 15601808 [TBL] [Abstract][Full Text] [Related]
19. Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine. Tannergren C; Petri N; Knutson L; Hedeland M; Bondesson U; Lennernäs H Clin Pharmacol Ther; 2003 Nov; 74(5):423-36. PubMed ID: 14586383 [TBL] [Abstract][Full Text] [Related]
20. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]